Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EDIT | AMGN | VRTX | REGN | GSK |
| Company | Editas Medicine | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.3000 | 311.82 | 505.42 | 658.00 | 39.29 |
| High | 1.3300 | 316.49 | 510.08 | 661.00 | 39.50 |
| Low | 1.2600 | 311.16 | 501.07 | 651.06 | 39.14 |
| Last | 1.3100 | 316.04 | 503.20 | 658.48 | 39.24 |
| Change | -0.0600 | +1.00 | -6.98 | -4.14 | -0.17 |
| % Change | -4.38% | +0.32% | -1.37% | -0.62% | -0.43% |
| Volume | 2,906,200 | 9,995,000 | 2,280,500 | 1,869,300 | 4,021,600 |
| 20-Day Average Volume | 3,301,870 | 3,393,335 | 1,374,950 | 970,965 | 5,467,740 |
| Previous Close | 1.3700 | 315.04 | 510.18 | 662.62 | 39.41 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6352 | 314.78 | 493.70 | 691.77 | 38.93 |
| 20-Day Raw Stochastic | 4.85% | 39.48% | 64.31% | 7.63% | 61.69% |
| 20-Day Relative Strength | 44.53% | 58.97% | 60.40% | 42.37% | 58.19% |
| Weighted Alpha | -82.69 | +13.53 | +21.28 | -37.00 | -3.44 |
| Today's Opinion | 80% Sell | 56% Buy | 72% Buy | 88% Sell | 56% Buy |
| Previous Opinion | 80% Sell | 56% Buy | 56% Buy | 80% Sell | 56% Buy |
| Last Month's Opinion | 40% Sell | 24% Sell | 24% Buy | 88% Sell | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.27% since 03/14/25 | +0.74% since 03/14/25 | -0.31% since 03/14/25 | -1.26% since 03/14/25 | -0.63% since 03/14/25 |
| Low | 1.2600 on 03/21/25 | 311.16 on 03/21/25 | 501.07 on 03/21/25 | 651.06 on 03/21/25 | 39.14 on 03/21/25 |
| High | 1.4400 on 03/18/25 | 319.31 on 03/18/25 | 517.20 on 03/17/25 | 679.83 on 03/17/25 | 40.47 on 03/17/25 |
| 1-Month | |||||
| %Chg | -31.77% since 02/21/25 | +4.30% since 02/21/25 | +3.92% since 02/21/25 | -5.98% since 02/21/25 | +7.10% since 02/21/25 |
| Low | 1.2600 on 03/21/25 | 303.10 on 02/27/25 | 473.51 on 02/27/25 | 651.06 on 03/21/25 | 36.72 on 02/24/25 |
| High | 2.2900 on 02/27/25 | 335.88 on 03/10/25 | 519.68 on 03/14/25 | 748.29 on 03/10/25 | 40.81 on 03/10/25 |
| 3-Month | |||||
| %Chg | unch since 12/20/24 | +19.99% since 12/20/24 | +26.66% since 12/20/24 | -6.18% since 12/20/24 | +16.79% since 12/20/24 |
| Low | 1.1200 on 02/11/25 | 257.05 on 01/06/25 | 390.92 on 12/23/24 | 642.00 on 02/04/25 | 31.72 on 01/14/25 |
| High | 3.2999 on 02/19/25 | 335.88 on 03/10/25 | 519.68 on 03/14/25 | 748.29 on 03/10/25 | 40.81 on 03/10/25 |
| 6-Month | |||||
| %Chg | -65.25% since 09/20/24 | -6.33% since 09/20/24 | +8.23% since 09/20/24 | -42.49% since 09/20/24 | -3.82% since 09/20/24 |
| Low | 1.1200 on 02/11/25 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 642.00 on 02/04/25 | 31.72 on 01/14/25 |
| High | 3.8000 on 10/21/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 1,154.56 on 09/23/24 | 41.80 on 10/09/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 108,699 | 169,778,272 | 129,216,736 | 71,988,312 | 81,218,568 |
| Shares Outstanding, K | 82,976 | 537,205 | 256,790 | 109,325 | 2,069,790 |
| Annual Sales | 32,310,000 | 33,424,000,000 | 11,020,100,000 | 14,202,000,000 | 40,095,390,000 |
| Annual Net Income | -237,090,000 | 4,090,000,000 | -535,600,000 | 4,412,600,000 | 3,290,590,000 |
| Last Quarter Sales | 30,610,000 | 9,086,000,000 | 2,912,000,000 | 3,789,200,000 | 10,387,570,000 |
| Last Quarter Net Income | -45,390,000 | 627,000,000 | 913,000,000 | 917,700,000 | 559,150,000 |
| 60-Month Beta | 1.88 | 0.53 | 0.41 | 0.27 | 0.58 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 03/05/25 | 5.31 on 02/04/25 | 3.98 on 02/10/25 | 12.07 on 02/04/25 | 0.59 on 02/05/25 |
| Latest Earnings Date | 05/14/25 | 05/01/25 | 05/05/25 | 05/01/25 | 05/07/25 |
| Most Recent Dividend | N/A | 2.380 on 02/14/25 | N/A | 0.880 on 02/20/25 | 0.393 on 02/21/25 |
| Next Ex-Dividends Date | N/A | 05/16/25 | N/A | 02/20/25 | 02/21/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.90 | 0.00 | 16.69 | 9.76 |